U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H18N3O3S.K
Molecular Weight 383.506
Optical Activity ( - )
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ESOMEPRAZOLE POTASSIUM

SMILES

[K+].COC1=CC2=C([N-]C(=N2)[S@@+]([O-])CC3=C(C)C(OC)=C(C)C=N3)C=C1

InChI

InChIKey=FOFFPEFVSRGLOZ-JIDHJSLPSA-N
InChI=1S/C17H18N3O3S.K/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17;/h5-8H,9H2,1-4H3;/q-1;+1/t24-;/m0./s1

HIDE SMILES / InChI
Molecular Formula K
Molecular Weight 39.0983
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C17H19N3O3S
Molecular Weight 345.416
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:33:50 UTC 2023
Edited
by admin
on Fri Dec 15 16:33:50 UTC 2023
Record UNII
F37S7G37O2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ESOMEPRAZOLE POTASSIUM
MART.   USAN   WHO-DD  
USAN  
Official Name English
NSC-759647
Code English
Esomeprazole potassium [WHO-DD]
Common Name English
1H-BENZIMIDAZOLE, 6-METHOXY-2-((S)-((4-METHOXY-3,5-DIMETHYL-2- PYRIDINYL)METHYL)SULFINYL)-, POTASSIUM SALT (1:1)
Common Name English
ESOMEPRAZOLE POTASSIUM [USAN]
Common Name English
ESOMEPRAZOLE POTASSIUM [MART.]
Common Name English
(-)-5-METHOXY-2-((S)-((4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL)METHYL)SULFINYL)-1H- BENZIMIDAZOLE POTASSIUM SALT
Common Name English
Code System Code Type Description
USAN
UU-66
Created by admin on Fri Dec 15 16:33:50 UTC 2023 , Edited by admin on Fri Dec 15 16:33:50 UTC 2023
PRIMARY
FDA UNII
F37S7G37O2
Created by admin on Fri Dec 15 16:33:50 UTC 2023 , Edited by admin on Fri Dec 15 16:33:50 UTC 2023
PRIMARY
EPA CompTox
DTXSID20167240
Created by admin on Fri Dec 15 16:33:50 UTC 2023 , Edited by admin on Fri Dec 15 16:33:50 UTC 2023
PRIMARY
EVMPD
SUB79200
Created by admin on Fri Dec 15 16:33:50 UTC 2023 , Edited by admin on Fri Dec 15 16:33:50 UTC 2023
PRIMARY
PUBCHEM
23672364
Created by admin on Fri Dec 15 16:33:50 UTC 2023 , Edited by admin on Fri Dec 15 16:33:50 UTC 2023
PRIMARY
SMS_ID
100000138850
Created by admin on Fri Dec 15 16:33:50 UTC 2023 , Edited by admin on Fri Dec 15 16:33:50 UTC 2023
PRIMARY
NCI_THESAURUS
C169962
Created by admin on Fri Dec 15 16:33:50 UTC 2023 , Edited by admin on Fri Dec 15 16:33:50 UTC 2023
PRIMARY
CAS
161796-84-5
Created by admin on Fri Dec 15 16:33:50 UTC 2023 , Edited by admin on Fri Dec 15 16:33:50 UTC 2023
PRIMARY
NSC
759647
Created by admin on Fri Dec 15 16:33:50 UTC 2023 , Edited by admin on Fri Dec 15 16:33:50 UTC 2023
PRIMARY
ChEMBL
CHEMBL1201320
Created by admin on Fri Dec 15 16:33:50 UTC 2023 , Edited by admin on Fri Dec 15 16:33:50 UTC 2023
PRIMARY
Related Record Type Details
Structure of ESOMEPRAZOLE
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of 3,10-DIMETHOXY-2,4-DIMETHYL-5H-BENZO(4,5)IMIDAZO(1,2-B)PYRIDO(1,2-D)(1,2,4)THIADIAZIN-13-IUM
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966